Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $86.67.
Several analysts recently issued reports on ACHC shares. Barclays dropped their target price on Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating on the stock in a report on Monday, September 30th. StockNews.com upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 4th. KeyCorp started coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Cantor Fitzgerald reiterated a “neutral” rating and issued a $90.00 price target on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Finally, Royal Bank of Canada restated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a research note on Friday, September 20th.
Check Out Our Latest Report on ACHC
Institutional Trading of Acadia Healthcare
Acadia Healthcare Trading Down 0.7 %
NASDAQ ACHC opened at $39.83 on Thursday. Acadia Healthcare has a 52 week low of $39.64 and a 52 week high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The stock’s 50 day moving average price is $59.60 and its two-hundred day moving average price is $66.10. The stock has a market capitalization of $3.70 billion, a price-to-earnings ratio of 13.06, a PEG ratio of 1.78 and a beta of 1.33.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $815.60 million during the quarter, compared to analysts’ expectations of $819.42 million. During the same quarter in the prior year, the company posted $0.91 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. As a group, analysts anticipate that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- There Are Different Types of Stock To Invest In
- Rocket Lab is the Right Stock for the Right Time
- What Are Dividend Challengers?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to invest in marijuana stocks in 7 steps
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.